Cancer

Lung Cancer Gene Test Predicts Who Needs Chemotherapy – Tumor Profiles Determines High Risk Patients

Scientists at Duke University have developed a genomic test to determine which patients with early-stage lung cancer need chemotherapy and which do not. They describe the chemotherapy as a “toxic regimen of drugs”.

The test could potentially save thousands of lives each year by allowing doctors to make the important recommendation for chemotherapy. The developers of the test, at Dukes Institute for Genome Sciences & Policy, say that some patients should receive it, but are currently advised against it.

Syndicate content
Share/Save/Bookmark

      

Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved